Item 9 Labs Corp (INLB)
Market Closed
25 Jul, 20:00
OTC PINK OTC PINK Primary $
0. 00
0
0%
$
70.18K Market Cap
- P/E Ratio
0% Div Yield
0 Volume
0 Eps
$ 0
Previous Close Day Range
0 0
Year Range
0 0
Want to track INLB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 19 days
Summary
INLB closed Friday higher at $0, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, INLB stock gained 0%.
INLB is not paying dividends to its shareholders.
The last earnings report, released on Nov 04, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Aug 19, 2025.
Item 9 Labs Corp has completed 1 stock splits, with the recent split occurring on Oct 18, 2018.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).
INLB Chart
Item 9 Labs Corp Dividends
INLB is not paying dividends to its shareholders.
Item 9 Labs Corp Earnings
| 19 Aug 2025 (In 2 weeks) Date | | - Cons. EPS | - EPS |
| 4 Nov 2024 Date | | - Cons. EPS | - EPS |
| 31 Oct 2024 Date | | - Cons. EPS | - EPS |
| 29 Oct 2024 Date | | - Cons. EPS | - EPS |
| 28 Oct 2024 Date | | - Cons. EPS | - EPS |
INLB is not paying dividends to its shareholders.
| 19 Aug 2025 (In 2 weeks) Date | | - Cons. EPS | - EPS |
| 4 Nov 2024 Date | | - Cons. EPS | - EPS |
| 31 Oct 2024 Date | | - Cons. EPS | - EPS |
| 29 Oct 2024 Date | | - Cons. EPS | - EPS |
| 28 Oct 2024 Date | | - Cons. EPS | - EPS |
Item 9 Labs Corp (INLB) FAQ
What is the stock price today?
The current price is $0.00.
On which exchange is it traded?
Item 9 Labs Corp is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is INLB.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0%.
What is its market cap?
As of today, the market cap is 70.18K.
When is the next earnings date?
The next earnings report will release on Aug 19, 2025.
Has Item 9 Labs Corp ever had a stock split?
Item 9 Labs Corp had 1 splits and the recent split was on Oct 18, 2018.
Item 9 Labs Corp Profile
| Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Jeffrey I. Rassas CEO | OTC PINK Exchange | 46564C203 Cusip |
| US Country | 97 Employees | - Last Dividend | 18 Oct 2018 Last Split | - IPO Date |
Overview
Item 9 Labs Corp. is distinguished as a vertically integrated cannabis company offering comprehensive operations and franchise opportunities within the United States. As a key player in the cannabis industry, it sustains a dynamic presence from cultivation to retail, focusing particularly on the Arizona market. The company's commitment to producing high-quality cannabis and cannabis-related products is matched by its innovative approach to dispensary franchising under its Unity Rd brand name. With its headquarters stationed in Phoenix, Arizona, Item 9 Labs Corp. pioneers in blending product excellence with franchise expertise, catering to both medical and adult-use cannabis consumers.
Products and Services
Item 9 Labs Corp. extends a diverse array of products and services tailored to meet the varied needs of the cannabis market:
- Flower: The company offers a range of cannabis flower options, cultivating strains to suit varied consumer preferences and needs. This staple product category represents the essence of cannabis in its most natural form, providing consumers with options ranging from sativa to indica and hybrid strains.
- Concentrates: Recognizing the demand for more potent cannabis products, Item 9 Labs Corp. produces concentrates that offer a heightened experience. This product line is crafted through extraction processes that isolate cannabinoids and terpenes to deliver products with increased potency and purity levels.
- Distillates: As part of their refined product offerings, distillates provide an even purer form of cannabis oil, free from impurities and residues. These products are versatile in use, catering to consumers seeking potency without the plant matter found in other forms.
- Hardware: To complement their product offerings, Item 9 Labs Corp. also supplies hardware items necessary for the consumption of cannabis and its derivatives. This range includes vaporizers and other devices designed to enhance the user experience with their products.
- Dispensary Franchises: Beyond product creation, Item 9 Labs Corp. empowers entrepreneurs through its Unity Rd franchise brand. This initiative allows for the establishment of licensed dispensaries that draw upon the company's industry expertise, offering both medical and adult-use cannabis products to the public. These franchises facilitate access to Item 9 Labs' premium products, alongside ensuring compliance and operational excellence in the rapidly evolving cannabis market.
Contact Information
Address: 2727 North 3rd Street
Phone: 833 867 6337
Website: https://www.item9labscorp.com
2025 © Marketlog. All Rights Reserved.
